未登录

Y

Yu-Long Lan

zhejiang university

H指数:25

被引数:1,417

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cellular subpopulation remodeling and biphasic molecular dynamics in glioma recurrence: a multi-omics analysis and diagnostic markers screening using liquid biopsy samples

胶质瘤复发的细胞亚群重塑和双相分子动力学：基于液体活检样本的多组学分析和诊断标志物筛选

Translational Oncology

IF4.1

2026-09-050

OAAI

Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights

小胶质细胞介导的吞噬作用在阿尔茨海默病中的机制、异质性与治疗启示

Biomolecules 2025, Vol. 15, Page 1629

IF4.8

2025-11-200

OAAI

Update on the roles of regular daily rhythms in combating brain tumors

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2025-01-010

PRE

Editorial: Immune metabolism in auto- and allo-immunity

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-09-250

OAAI

Update on the intriguing roles of AQP4 expression and redistribution in the progression and treatment of glioma

ANNALS OF MEDICINE

IF4.3

2024-09-090

OAAI

Analysis of the sodium pump subunit ATP1A3 in glioma patients: Potential value in prognostic prediction and immunotherapy

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-05-010

PRE

The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2024-03-136

PRE

Shed a New Light on Spinal Cord Injury-induced Permanent Paralysis with the Brain-spine Interface

NEUROSCIENCE BULLETIN

IF5.8

2023-09-280

OA

Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway (vol 37, 248, 2018)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-09-160

OAAI

The role of ATP1A3 gene in epilepsy: We need to know more

FRONTIERS IN CELLULAR NEUROSCIENCE

IF4

2023-02-136

OAAI

Identification of the prognostic and immunological roles of aquaporin 4: A potential target for survival and immunotherapy in glioma patients

FRONTIERS IN CELLULAR NEUROSCIENCE

IF4

2022-11-298

OAAI

The Promoting Effect of Traumatic Brain Injury on the Incidence and Progression of Glioma: A Review of Clinical and Experimental Research

inflammation research

IF4.1

2021-08-0110

OA

Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2021-05-015

OAAI

Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβkinase activity and interrupting NF-κB/COX-2-mediated signaling cascades (vol 36, 93, 2017)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2020-09-230

OAAI

Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway

CANCER BIOLOGY & MEDICINE

IF8.4

2020-01-0133

OAAI

Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794

CELL PROLIFERATION

IF5.6

2019-11-2020

OAAI

Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM

IF4.6

2019-09-2032

OAAI

The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway

CELL BIOLOGY AND TOXICOLOGY

IF5.9

2019-02-0928

PREAI

Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM

IF4.6

2019-01-2921

OAAI

Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2018-10-12121

OAAI